Bicara Therapeutics

This study is testing a new drug called ficerafusp alfa, which is designed to attack cancer cells in two ways at once. It is being given alongside an existing immunotherapy drug (pembrolizumab) to people with advanced head and neck cancer that has returned or spread. The goal is …